09:41 AM EST - WPD Pharmaceuticals Inc. : Announced that it has received a prepayment of approximately C$705,000 (2,000,000 PLN) and approval for reimbursement of approximately C$175,000 (500,000 PLN) from the Polish National Center for Research and Development (“NCRD”) granted by the European Union, under the Smart Growth Operational Program 2014-2020, for the further development of WPD101, the Company’s drug candidate targeting glioblastoma (“GBM”) which includes Phase I clinical studies. WPD Pharmaceuticals Inc.
shares C.WBIO are trading up 2 cents at $0.29.
